Improving experience through reliable coverage
Improving Experience Through Reliable Coverage
UK Biobank: A case-study of biomedical research with Databanks and its privacy and data protection considerations
In a previous blog post, we outlined the typical privacy and data protection implications of conducting biomedical research using personal data from health databanks.
Kadans Science Partner completes construction of primary structure on purpose built laboratory building at Merlin Place, North Cambridge
Topping out ceremony gathered key stakeholders on Cambridge Wide Open Day to celebrate progress in development of new laboratory facilities139,000 sq ft of flexible lab and office space, due for completion Q3 2026Cambridge, UK, 13 June 2025:
The clock’s ticking for Windows 10: Are you ready?
14th October 2025.
Does that date look familiar? If you’re using Windows 10, it should. It’s the day Microsoft pulls free support for the operating system.
EFEC’s role in advancing UK-China life sciences collaboration at MTI Expo 2025
Excellence First Enterprise Consultancy Ltd (EFEC) continues to play a pivotal role in bridging the UK and China across education, talent, and innovation ecosystems, with a particular focus on life sciences and healthcare technology. At the 2025 UK Medical Technology Innovation Expo (MTI Expo 2025), EFEC’s activities underscored its position as a key facilitator of cross-border innovation and…
Accelerate@Babraham 2025 announces new cohort
Five new ventures secure the chance to be part of Babraham Research Campus - a leading location for early-stage life science start-ups.
Learn more about the Wilson Pro DAS
Every building presents its own connectivity challenges. Zinwave’s wideband DAS is engineered to adapt and perform in complex environments, delivering consistent and reliable coverage.
How surrogate models enhance medical device optimisation
Design optimisation is a fundamental step in developing innovative and efficient medical devices. Before committing to manufacturing prototypes, simulations and models are developed to indicate the expected performance of the medical device design. They offer great precision however, they are computationally expensive and time-consuming to develop, especially for iterative processes like…
Norovirus vaccines - closer than you think
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis, publishes a brand-new global demand assessment for new norovirus vaccines.
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its C
Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy
Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery
Kerry Elden joins Salus Wellness
The team at Salus are pleased to announce that Kerry Elden has joined Salus Wellness this month.
Tagomics awarded £860k Innovate UK Biomedical Catalyst grant for detection of colorectal cancer
Grant forms part of £1.2M project to customise Tagomics’ multiomic profiling platform for early detection of colorectal cancerEarly detection test to be developed in collaboration with the Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection biobank
Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional immunotherapy against Gram-negative bacterial infections
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infectionsNovel bifunctional molecule based on Alphamer platform demonstrated direct, broad-spectrum antibacterial activity in vitro and in vivo, with e
Supporting our clients globally - Team Consulting welcomes David Maltz
As part of our continued international growth, Team Consulting is pleased to welcome David Maltz as the newest member of our commercial team.
How to prove the ROI of your content marketing in science and tech
Avoid another awkward boardroom moment where the marketing ROI question leaves you fumbling- this article shows you how to prove your content’s impact with clarity and confidence.
Cambridge NeuroWorks Fellows showcase innovation at connecting neuroscience workshop
Cambridge NeuroWorks Fellows had a brilliant opportunity to showcase their research at the Cambridge NeuroWorks Connecting Neuroscience event, held in collaboration with Cambridge Neuroscience and Cambridge Network.
Cambridge plays host to global gathering on Parkinson’s research
Cambridge continues to prove itself as a world-class destination for conferences, as it welcomed the prestigious Alpha Synuclein Conference.
Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
SB000 reverses cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotencyStudy advances efforts towards next-generation rejuvenation therapeutics with applications across age-driven diseas
More on the Wilson Pro Enterprise 4330
Stronger signals, better communication—everywhere indoorsExperience seamless communication and improved coverage within large buildings with our In-building wireless solutions.
What it takes to get ahead in biotech
By Priya Kalia, SciTribe and Miranda Weston-Smith, BioBeat.
Brain injury survivors help shape new medical technologies
Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors.
“Think like a car salesperson”: What biotech and AI start-ups can learn about selling
For many UK start-ups in biotech and AI, selling doesn’t come naturally. Founders are often scientists, engineers, developers or researchers, brilliant at building, but less comfortable with business. Yet, no matter how innovative your product is, it won’t make an impact unless someone buys it. To explore how technical founders can become more effective at sales, we spoke with Gary Jennings,…
Baby’s microbiome may protect against childhood viral infection
A baby's makeup of gut bacteria — their microbiome — which starts to form as soon as they are born, could help protect against viral infections later in childhood, a new study suggests.
From Hit to Clinic: Isogenica and Charles River Collaborate to Accelerate Next-Generation Peptide and VHH Discovery
Every breakthrough begins with discovery. Isogenica, a leader in synthetic VHH antibody and peptide discovery, has announced a collaboration with Charles River, a leading, global provider of drug discovery, development, and manufacturing solutions, to help biotech companies streamline discovery and accelerate progress toward clinic-ready therapeutics. This collaboration unites Isogenica’s…